SS Innovations 獲2026年外科機械人行業傑出公司大獎 SSi Mantra手術量突破1.1萬例

EX-99.1
2
ea029635901ex99-1.htm
PRESS RELEASE, DATED JUNE 30, 2026

 

Exhibit
99.1

 

 

SS
Innovations Named Outstanding Company Winner at the 2026 Surgical Robotics Industry Awards 

Company
celebrated for advancing global access to its innovative robotic surgery platform

 

Fort
Lauderdale, FL – June 30, 2026
– SS Innovations International, Inc. (the “Company” or “SS Innovations”) (Nasdaq: SSII), a developer
of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today
announced that the Company was named the winner of the Outstanding Company category at the 2026 Surgical Robotics Industry Awards (“SRIA”).

 

Each
year, in the Outstanding Company category, SRIA recognizes a single winning surgical robotics company that demonstrates one or more of
the following characteristics:

 

●an
 outstanding business or commercial success;

●a
 highly novel and/or inventive product, process, service, technology or procedure;

●policies,
 processes, products or services with a positive environmental or societal impact;

●recognition
 as an industry leading company by customers or the public;

●a
 positive stance on ethics/values; and

●standing
 as an excellent employer of choice.

 

Dr.
Sudhir Srivastava, Chairman of the Board and Chief Executive Officer of SS Innovations, commented, “We are delighted and honored
to be named the Outstanding Company winner at this year’s prestigious Surgical Robotics Industry Awards. SS Innovations surpassed
nine other well-established finalists to win this coveted industry accolade, which reflects our commitment to advancing surgical robotic
technologies and democratizing global access to expert surgical care. We believe that surgeons and hospitals are embracing the SSi Mantra
surgical robotic system due to its cutting-edge surgical robotic technology, differentiated features, user friendliness, training capabilities,
and cost efficiency.”

 

To
learn more about the Surgical Robotics Industry Awards visit: www.surgicalroboticsindustryawards.com.

 

As
of June 22, 2026, the cumulative number of multi-specialty procedures completed with the SSi Mantra surgical robotic system totaled 11,719,
including 612 cardiac procedures, 175 telesurgeries, and 212 pediatric surgeries. Additionally, approximately 2,100 physicians have been
trained on the SSi Mantra, which has been utilized to perform over 170 different types of procedures.

 

To
date, the SSi Mantra has been granted regulatory approval in 14 countries, including:

 

●Colombia

●Ecuador

●Guatemala

●Guyana

●India

●Indonesia

●Iraq

●Kenya

●Nepal

●Oman

●Philippines

●Sri
 Lanka

●Ukraine

●United
 Arab Emirates

 

About
SS Innovations 

 

SS
Innovations International, Inc. (Nasdaq: SSII) develops innovative surgical robotic technologies with a vision to make the benefits of
robotic surgery affordable and accessible to a larger segment of the global population. The Company’s product range includes its
proprietary “SSi Mantra” surgical robotic system and its comprehensive suite of “SSi Mudra” surgical instruments,
which support a variety of surgical robotic procedures including cardiac surgery. An American company headquartered in India, SS Innovations
plans to expand the global presence of its technologically advanced, user-friendly, and cost-effective surgical robotic solutions. Visit
the Company’s website at ssinnovations.com or LinkedIn for more information and updates.

 

  

  

 

 

About
the SSi Mantra

 

The
SSi Mantra is a user-friendly, modular, multi-arm system with advanced technology features, including: 3 to 5 modular robotic arms, an
open-faced ergonomic surgeon command center, a large 3D 4K monitor, a touch panel monitor for all patient related information display,
a virtual real-time image of the robotic patient side arm carts, and the ability for superimposition of 3D models of diagnostic imaging.
The optional SSi MantrAsana tele-surgeon console is a portable, compact alternative to the SSi Mantra’s standard surgeon command
center that provides equivalent control functionality while enabling enhanced portability, ergonomic flexibility, and telesurgery capability.
The SSi Mantra utilizes over 40 different types of robotic endo-surgical instruments to support different specialties, including cardiac
surgery, and 5mm instruments for the pediatric population and ENT surgeries. A vision cart provides the table-side team with the same
magnified 3D 4K view as the surgeon to provide better safety and efficiency. The SSi Mantra has been clinically validated in India in
more than 170 different types of surgical procedures.

 

Forward
Looking Statements

 

This
press release may contain statements that are not historical facts and are considered forward-looking within the meaning of the Private
Securities Litigation Reform Act of 1995. The words “anticipate,” “assume,” “believe,” “estimate,”
“expect,” “will,” “intend,” “may,” “plan,” “project,” “should,”
“could,” “seek,” “designed,” “potential,” “forecast,” “target,”
“objective,” “goal,” or the negatives of such terms or other similar expressions to identify such forward-looking
statements. These statements relate to future events or SS Innovations’ future financial performance and involve known and unknown
risks, uncertainties and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially
different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements.

 

Investor
Contact:

 

The
Equity Group

Kalle
Ahl, CFA

T:
(303) 953-9878

[email protected]

 

Devin
Sullivan, Managing Director

T:
(212) 836-9608

[email protected]

 

Media
Contact:

 

RooneyPartners
LLC

Kate
Barrette

T:
(212) 223-0561

[email protected]